|
VPS53 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.436000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.045600E-02 |
| Normal-vs-Stage2 |
6.385000E-01 |
| Normal-vs-Stage3 |
1.765960E-01 |
| Normal-vs-Stage4 |
2.434200E-02 |
| Stage1-vs-Stage2 |
4.399900E-02 |
| Stage1-vs-Stage3 |
5.610600E-01 |
| Stage1-vs-Stage4 |
5.033200E-01 |
| Stage2-vs-Stage3 |
1.171850E-01 |
| Stage2-vs-Stage4 |
2.351900E-02 |
| Stage3-vs-Stage4 |
3.016600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.005600E-02 |
| Normal-vs-AfricanAmerican |
4.639200E-01 |
| Normal-vs-Asian |
1.257370E-01 |
| Caucasian-vs-AfricanAmerican |
2.774300E-02 |
| Caucasian-vs-Asian |
9.076800E-01 |
| AfricanAmerican-vs-Asian |
5.932300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.150610E-01 |
| Normal-vs-Female |
1.069220E-01 |
| Male-vs-Female |
8.792200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.656500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.509370E-01 |
| Normal-vs-Age(61-80Yrs) |
2.809400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.397600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.691000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.824400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.360600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.251800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.468000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.727200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.330600E-01 |
| Classical-VS-Follicular |
4.017800E-01 |
| Classical-VS-Other |
1.907820E-01 |
| Classical-VS-Normal |
2.471000E-01 |
| Tall-VS-Follicular |
5.933800E-01 |
| Tall-VS-Other |
4.875200E-01 |
| Tall-VS-Normal |
6.683500E-02 |
| Follicular-VS-Other |
3.668600E-01 |
| Follicular-VS-Normal |
1.370780E-01 |
| Other-VS-Normal |
7.439500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.799200E-01 |
| Normal-vs-N1 |
2.301800E-02 |
| N0-vs-N1 |
2.072600E-01 |
|
|
